PERJETA® (pertuzumab) is indicated for use in combination with Herceptin® (trastuzumab) and chemotherapy for
An error occurred while loading this portion of content. We are resolving this issue and apologize for the inconvenience.
Please check back soon for an update.
Left Ventricular Dysfunction (LVD)
Metastatic Breast Cancer
Neoadjuvant Treatment of Breast Cancer
Adjuvant Treatment of Breast Cancer
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.
This website is intended for US healthcare professionals only. If you are not a healthcare professional, please let us know so we can redirect you to the correct site: